1.100USD+1.100After-hours 07/31, 20:00 (ET)
1.98MMarket Cap
LossP/E TTM
Sonoma Pharmaceuticals Inc
Key Figures
1.120Open
1.140High
28.58KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.59%Turnover Ratio
1.130Prev. Close
1.100Low
29.39KTurnover
LossP/E Static
0.64P/B
0.00%Div Yield TTM
-24.70%ROA
6.92052wk High
0.80Volume Ratio
-3.46MNet Profit
1.80MShares
-1.9416EPS TTM
1.29Beta
-81.19%ROE
0.85052wk Low
3.54%Amplitude
39.22%Gross Margin
1.98MMarket Cap
-1.61Reward/Risk
4.12%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Sonoma Pharmaceuticals Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 114 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 14.80.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sonoma Pharmaceuticals Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Sonoma Pharmaceuticals Inc Highlights
StrengthsRisks
Sonoma Pharmaceuticals Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Sonoma Pharmaceuticals Inc
SNOA
0
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Sonoma Pharmaceuticals Inc Info
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
Ticker SymbolSNOA
CompanySonoma Pharmaceuticals Inc
CEOTrombly (Amy)
Websitehttps://sonomapharma.com/
Shareholders
FAQs
What is the current price of Sonoma Pharmaceuticals Inc (SNOA)?
The current price of Sonoma Pharmaceuticals Inc (SNOA) is 1.10.
What is the symbol of Sonoma Pharmaceuticals Inc?
The ticker symbol of Sonoma Pharmaceuticals Inc is SNOA.
What is the 52-week high of Sonoma Pharmaceuticals Inc?
The 52-week high of Sonoma Pharmaceuticals Inc is 6.92.
What is the 52-week low of Sonoma Pharmaceuticals Inc?
The 52-week low of Sonoma Pharmaceuticals Inc is 0.85.
What is the market capitalization of Sonoma Pharmaceuticals Inc?
The market capitalization of Sonoma Pharmaceuticals Inc is 1.98M.
What is the Earnings Per Share (EPS TTM) of Sonoma Pharmaceuticals Inc (SNOA)?
The Earnings Per Share (EPS TTM) of Sonoma Pharmaceuticals Inc (SNOA) is -1.89.